2022 Senate Bill 890

Establish prescription drug price controls

Introduced in the Senate

Feb. 24, 2022

Introduced by Sen. Dayna Polehanki (D-7)

To earmark certain license fees imposed on prescription drug makers to a government “prescription drug affordability fund” Senate Bill 889 would authorize.

Referred to the Committee on Health Policy and Human Services